Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will hold its Annual Meeting of Stockholders on Thursday, May 17, 2012 beginning at 9:00 AM Eastern at the InterContinental Harbor Court, 550 Light Street, Baltimore, Maryland 21202.
Following the formal portion of the meeting, a member of the company’s senior management will provide a brief corporate update, including a discussion of the company’s business activities, financial outlook and current news.
Interested parties may listen to the Annual Meeting via webcast by visiting the Emergent BioSolutions website at www.emergentbiosolutions.com. The webcast will be archived on the company’s website under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.